CILcare is the world-leading R&D services company specialized in hearing and otic disorders.
CILcare proposes laboratory services and consultancy to assess the safety, efficacy and exposition of drug candidates on preclinical pharmacological models of hearing loss, tinnitus, ototoxicity and otitis.
The importance of investigating tinnitus and hearing loss is well-known, however the underlying fundamental knowledge, based on preclinical models and the translational mindset, is severely lacking. CILcare is commited to filling this gap by providing means to validate hypotheses toward solutions able to prevent and to reduce hearing and otic disorders.
The company is located in Boston (USA), Montpellier and Paris (France). CILcare benefits from strong expertise and an industrial background as well as an international network of clients and partners.